Market Overview

JPMorgan Upgrades AK Steel Amid Cleveland-Cliffs Acquisition

Share:
JPMorgan Upgrades AK Steel Amid Cleveland-Cliffs Acquisition

AK Steel Holding Corporation (NYSE: AKS) has entered into a definitive merger agreement with Cleveland-Cliffs Inc (NYSE: CLF), in which the latter will acquire all the shares of the steelmaker.

Cleveland-Cliffs’ proposed acquisition of would likely be approved, with no antitrust opposition or another bidder emerging, according to JP Morgan.

The Analyst

JPMorgan’s Michael Gambardella upgraded AK Steel from Underweight to Neutral.

The Thesis

AK Steel’s shares are currently trading in-line with the transaction value offered by Cleveland-Cliffs and the $3 billion deal should “go through as proposed,” Gambardella said in the upgrade note.

Referring to the terms of the offer, the analyst said that the all-stock transaction had an exchange ratio of 0.400x.

“Additionally, at its current price, AKS is trading at 2019E and 2020E EV/EBITDA multiples of 6.3x and 7.2x, respectively, compared with its average forward multiple over the last three years of roughly 6.4x,” Gambardella wrote.

AK Steel Price Action

Shares of AK Steel Holding had risen more than 3% to $3.12 at the time of publishing on Wednesday.

Latest Ratings for AKS

DateFirmActionFromTo
Dec 2019UpgradesUnderweightNeutral
Nov 2019MaintainsSell
Sep 2019DowngradesOverweightUnderweight

View More Analyst Ratings for AKS
View the Latest Analyst Ratings

Posted-In: JP Morgan Michael GambardellaAnalyst Color Upgrades Analyst Ratings Best of Benzinga

 

Related Articles (AKS + CLF)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ABBBarclaysInitiates Coverage On
DPLOWilliam BlairUpgrades
SUPVItau BBADowngrades
GGALItau BBADowngrades
BMAItau BBADowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Mid-Day Market Update: Crude Oil Up 4%; Revance Therapeutics Shares Plunge

PreMarket Prep Recap: Trade Tug Of War Continues, Stormy Guidance From Cloud Stocks